Mangrove Lithium Financial Model

• Core technology: Mangrove's electrochemical process directly converts lithium chloride (LiCl from brine) into battery-grade lithium hydroxide monohydrate (LiOH·H₂O) without producing lithium carbonate as an intermediate.
• Key advantages claimed:
• Eliminates CAPEX and OPEX of a separate LiOH conversion plant.
• Removes chemical phase-separation steps that introduce impurities in conventional process.
• Enables battery-grade LiOH from Salar brines (the largest global lithium reserves) which conventional processing cannot reliably achieve.
• Positioning: "Lowest cost" battery-grade LiOH producer, enabling brine assets (Lithium Triangle) to supply the high-growth NMC/NCA cathode market.

• Demand context: Lithium supply bottlenecks projected to limit EV adoption by >350 million EVs.
• Demand chart (Benchmark Mineral Intelligence, Q4 2019): Total LiOH/LiCO₃ demand reaches ~5,500,000–6,000,000 tonnes LCE by 2040 vs. operational + probable supply of ~1,500,000–1,700,000 tonnes - implying a large structural supply gap from ~2024 onward.
• Reserve context: Lithium Triangle holds the largest global reserves - Argentina 14.8 Mt, Bolivia 9 Mt, Chile 8.5 Mt (all brine-dominant assets).

• Technology licensing / royalty per tonne of LiOH produced - common for process-IP companies; aligns with "Mangrove plant" language suggesting modular skids sold or licensed to brine operators.
• Tolling / offtake - Mangrove builds and operates plants, sells LiOH directly. Not evidenced.
• Joint venture with brine asset owners. Not evidenced.

No pricing, contract terms, revenue per unit, or customer names appear in deck.

• Commercial-scale demonstration plant: fully integrated operation since 2019.
• No revenue figures, customer names, signed offtakes, tonnes produced, or conversion efficiency data shown in deck.

• Problem with incumbents: Conventional brine producers (SQM, Albemarle, Livent) must build both a carbonate and a hydroxide plant - higher cost and impurity issues.
• Hard-rock (spodumene) producers supply most of current LiOH but at higher cost; deck asserts Mangrove enables brine to undercut hard-rock on LiOH cost.
• Moat claimed: Proprietary electrochemical process (IP not detailed). Demonstration plant operational since 2019 suggests a meaningful technical lead.

• Founder/presenter: Saad Dara.

• Archetype + why: Commodity process-technology project finance model (single-product, cost-driven). Mangrove is a capital-intensive process technology company whose value is denominated in $/tonne LiOH produced and plant economics. The appropriate model is a plant-level project finance / techno-economic model combined with a technology licensing P&L if the commercial model is IP-licensing. Primary outputs: cost of production (OPEX $/t LiOH), capital intensity (CAPEX $/t capacity), revenue per tonne vs. spot LiOH price, and IRR/NPV per plant. A 3-statement corporate model sits on top once the licensing/tolling structure is confirmed.

• Forecast horizon & granularity:
• Plant-level: Year 0–3 construction + 15–20 year operating life (standard for process plants).
• Corporate: Annual, 5–10 year horizon; monthly for first 2 years post-commercialisation.

• Key drivers & assumptions:
• LiOH spot price ($/t): ~$15,000–$25,000/t battery-grade LiOH (2023–2025 range; highly volatile - key scenario lever).
• Plant nameplate capacity (t LiOH/yr): scale-up from demo; first commercial plant likely 5,000–20,000 t/yr range; needs confirmation from management.
• CAPEX per tonne of annual capacity: ~$1,000–$2,000/t (lower than conventional dual-plant; this is the core value claim - must be stress-tested).
• OPEX per tonne (electricity, reagents, labour): electrochemical processes are electricity-intensive; assume $3,000–$6,000/t; electricity cost and efficiency (kWh/t LiOH) is the critical driver.
• Brine feed LiCl grade and recovery rate: dependent on Salar; typical brine lithium grade 0.05–0.15% Li; recovery rate 80–90%.
• Ramp-up schedule (% of nameplate by year): Year 1: 50%, Year 2: 80%, Year 3+: 95%.
• Royalty/licence rate (if licensing model): $500–$2,000/t LiOH or % of revenue; structure unknown.
• Number of plants licensed/built (growth driver): 1 commercial plant Year 1, scaling to 3–5 by Year 5.
• Debt/equity mix for plant construction: 60/40 debt/equity typical for project finance; cost of debt 6–8%.
• LiOH demand growth and supply-gap timing: supply gap widens materially post-2024 per Benchmark Mineral Intelligence.

• Scenarios (Base / Bull / Bear - which variables flex):
• Bear: LiOH price $12,000/t; CAPEX overrun +30%; single plant; ramp delayed 12 months.
• Base: LiOH price $18,000/t; CAPEX on plan; 3 plants by Year 5; ramp per schedule.
• Bull: LiOH price $25,000/t; CAPEX beat −15%; 5 plants by Year 5; strategic partnership with Tier-1 brine operator.

• Required sheets / outputs:

1. Assumptions - all drivers, switchboard for scenarios.
2. Plant Operating Model - production schedule, OPEX build-up, CAPEX schedule per plant.
3. Revenue - tonnes sold × LiOH price (or royalty rate × tonnes); by plant.
4. Income Statement - EBIT, EBITDA, net income (corporate level).
5. Capital Structure / Project Finance - debt drawdown, repayment, DSCR, equity IRR.
6. Cash Flow Statement - operating, investing, financing; free cash flow.
7. Balance Sheet (simplified).
8. Valuation - DCF on corporate FCF; EV/EBITDA comparable check.
9. Sensitivity Tables - LiOH price × OPEX; CAPEX × # of plants.